Sildenafil

Inhibits phosphodiesterase-5, preserving and amplifying nitric-oxide–mediated smooth-muscle relaxation in corpus cavernosum and pulmonary vasculature.

CardiovascularVascularEnzyme inhibitionSignalling pathway modulation

Primary Mechanism of Action

Clinical / Scientific

Sexual or endothelial NO stimulates guanylate cyclase to form , which relaxes smooth muscle. hydrolyzes ; sildenafil inhibits , so persists and vasodilation is potentiated in tissues that express .

Pathway Targets

PDE5

Scientific explanation

Competitive inhibition of hydrolysis.

NO / cGMP signalling

Scientific explanation

Amplification of existing nitric-oxide signals — not NO generation de novo.

Pathway Convergence

Clinical / Scientific

Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.

cGMP-preserving vasodilation

Target to downstream effect: Endothelial or nitrergic NO → cGMP formation → PDE5 inhibition → Sustained smooth-muscle relaxation

Endothelial or nitrergic NO
↓
cGMP formation
↓
PDE5 inhibition
↓
Sustained smooth-muscle relaxation

Mechanistically Relevant Repurposed & Adjunctive Applications

Erectile dysfunction

Established

Mechanistic rationale

Established labelled indication.

Pulmonary arterial hypertension (specific products/doses)

Established

Mechanistic rationale

inhibition in pulmonary vasculature is an established PAH mechanism for appropriately labelled products and doses — not automatically identical to ED regimens.

Mechanistic Application Matrix

Biological TargetMechanismPotential RelevanceEvidence Level
PDE5InhibitioncGMP persistence / vasodilationEstablished mechanism

Mechanistic Interaction Considerations

Absolute contraindication with nitrates due to profound hypotension. Caution with other antihypertensives, alpha-blockers, and strong inhibitors. Avoid combining inhibitors without clinical direction.

In Plain Language

An erection and some blood-vessel relaxation depend on a signal called . is the that breaks down. Sildenafil pauses that so an existing nitric-oxide signal lasts longer. It does not create desire or nitric oxide from nothing.

Compounds Sharing Pathways

Other library compounds whose structured pathway data overlap this ingredient. Shared pathways are not combination recommendations.

NO / cGMP signalling

Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.